Delta Med Group and DBM announce a strategic partnership to strengthen their positioning in the pre-filled syringes market

Milan, April 13, 2023 – Delta Med Group announces a partnership with DBM, a leading manufacturer of pre-filled syringes. The Cadringher family will reinvest in the Group and Roberto Cadringher – current majority shareholder of DBM – will play a central role in the Group, continuing to lead DBM and joining Delta Med’s Board of Directors.

Delta Med Group and DBM will expand their portfolio profiting from highly complementary products and R&D capabilities, improving their ability to serve customers. The partnership will generate significant synergies and boost the growth trajectory of the combined entity.

The combination of the two companies with c.€100 million of revenue, more than 300 employees and a direct presence in Italy and France will be better equipped to compete at the international level, leveraging a fully-fledged product portfolio and a state-of-the-art R&D department.

Delta Med Group will continue to invest in family-owned companies with proprietary products that have proven to be leaders in their specific segments, supported by entrepreneurs with proven experience and capabilities.

White Bridge Investments, main shareholder of Delta Med, will retain the majority of the Group.

Roberto Cadringher, CEO of DBM stated: “We are excited to join forces with the other companies of the Group. This partnership will enable all Group entities to leverage the complementarity of their products and to provide an even more comprehensive service. The synergies that can be realized will further accelerate the growth and development trajectory. I will continue to lead DBM and provide support to the Group.”

Gabriele Giovanelli, CEO of the Delta Med Group, added: “DBM is a well-recognized player in the space for the production of pre-filled syringes and represents a key building block for our project. The addition of DBM into the Group will allow us to better serve a continuously rising demand.”

Delta Med was assisted by White&Case as legal advisor, with the partners Leonardo Graffi and Alessandro Seganfreddo and the associate Stefania Maracich. Athena was responsible for the financial due diligence with a team led by Luisa Spadari. Deloitte assisted Delta Med in the tax and fiscal aspects of the transaction, with a team led by Mario De Blasi.

DBM and its partners were assisted by Nicolò Del Guerra and Domenico Zalum as legal advisors and by Carlotta Gagliano for specific tax aspects. Nicola Boni from Vitale-Zane & Co. acted as financial advisor. Corrado Pozzi from Studio Pozzi – Dottori Commercialisti Associati – assisted DBM in the fiscal aspects of the transaction.


The pages of this website are intended for health professionals only.

The information they contain is to be understood as intended for these users only. Therefore, to visit these pages, I hereby declare under my own responsibility that I belong to the aforementioned professional category.

With reference to the supplement to the circular of 23/03/2006, issued on 20/04/2010 by the Italian Ministry of Health, concerning the advertising of medical devices, only doctors, pharmacists and other health professionals may consult the contents of this website.

1. Information.

This website contains information intended solely for medical doctors and health professionals. D.B.M. Srl shall not be held liable for access by third parties to the information pages for health professionals as specified above. The medical device descriptions presented on these pages are for information purposes only and are not for advertising purposes. The information on this website is of a general nature and is not an alternative to seeking appropriate medical treatment, nor is it intended to advertise any medical procedures. Patients should speak to their doctor to assess treatment options, risks and benefits.

2.  Links.

All links on this website are provided for your convenience only. D.B.M. Srl accepts no responsibility for the contents of third-party websites. With regard to the links on its website, D.B.M. Srl expressly excludes any intentions other than that of merely providing information.

3.  Intellectual property.

All text, images, drawings and attachments are the exclusive property of D.B.M. Srl. Anyone using them improperly or without authorisation will be prosecuted.